TSXV:BTI.H - Post by User
Comment by
prophetoffactzon Mar 01, 2023 10:39am
134 Views
Post# 35312351
RE:RE:$5.25 million
RE:RE:$5.25 millionfuzzyjr wrote: Somethings got to give soon.
glts
It will be interesting. Is BTI a zero or hero?
There are a number of different possibilities to add value at $.02 as has been outlined.
I originally hoped for a Saltarelli - a deal consistent with Saltarelli's historic success. He's chosen to stay with BTI when he could easily go elsewhere. He's said xB3 should be able to perform equal to or better than DNLI. We have the validation from Chiesi, and the multi-product option from the word's largest healthcare company(J&J). Saltarelli is on Chiesi's xB3 Advisory Board and again he's stayed with BTI and Lysosomal Storage has become a strategic focus.
Then we had a potential Saltarelli on steriods in the Biodexa deal which the former Group Finance Director of Shire challenged anyone to find more opportunity than at its market cap. WoW! Successfull fund Armistice Group wanted the whole Biodexa financing. BTI was more highly valued than Midatech in the Biodexa deal and Midatech has secured a financing.
Zero or hero? It all depends on execution. Rathjen aimed for the stars with the Biodexa deal. Can she put an alternative together with limited time and resources?